Phio Pharmaceuticals Corp (PHIO)
0.70
-0.03
(-3.62%)
USD |
NASDAQ |
Jun 26, 11:40
Phio Pharmaceuticals Free Cash Flow: -10.05M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -10.05M |
| December 31, 2023 | -10.75M |
| September 30, 2023 | -11.09M |
| June 30, 2023 | -11.72M |
| March 31, 2023 | -11.38M |
| December 31, 2022 | -12.25M |
| September 30, 2022 | -12.02M |
| June 30, 2022 | -11.38M |
| March 31, 2022 | -12.21M |
| December 31, 2021 | -11.91M |
| September 30, 2021 | -12.06M |
| June 30, 2021 | -11.14M |
| March 31, 2021 | -9.907M |
| December 31, 2020 | -8.821M |
| September 30, 2020 | -8.738M |
| June 30, 2020 | -8.811M |
| March 31, 2020 | -8.727M |
| December 31, 2019 | -8.717M |
| September 30, 2019 | -7.922M |
| June 30, 2019 | -7.877M |
| March 31, 2019 | -7.789M |
| December 31, 2018 | -7.52M |
| September 30, 2018 | -7.975M |
| June 30, 2018 | -8.18M |
| March 31, 2018 | -8.823M |
| Date | Value |
|---|---|
| December 31, 2017 | -9.717M |
| September 30, 2017 | -8.89M |
| June 30, 2017 | -8.283M |
| March 31, 2017 | -7.64M |
| December 31, 2016 | -7.764M |
| September 30, 2016 | -7.99M |
| June 30, 2016 | -8.348M |
| March 31, 2016 | -8.319M |
| December 31, 2015 | -7.374M |
| September 30, 2015 | -7.378M |
| June 30, 2015 | -7.196M |
| March 31, 2015 | -7.453M |
| December 31, 2014 | -7.853M |
| September 30, 2014 | -7.719M |
| June 30, 2014 | -7.671M |
| March 31, 2014 | -7.641M |
| December 31, 2013 | -6.389M |
| September 30, 2013 | -6.075M |
| June 30, 2013 | -5.602M |
| March 31, 2013 | -4.996M |
| December 31, 2012 | -5.077M |
| September 30, 2012 | -6.737M |
| June 30, 2012 | -7.594M |
| March 31, 2012 | -8.19M |
| December 31, 2011 | -10.05M |
Free Cash Flow Range, Past 5 Years
-12.25M
Minimum
Dec 2022
-7.877M
Maximum
Jun 2019
-10.37M
Average
-10.92M
Median
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
| Theriva Biologics Inc | -18.27M |
| Oragenics Inc | -8.246M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.011M |
| Cash from Financing (Quarterly) | -0.004M |
| Free Cash Flow Per Share (Quarterly) | -0.4391 |
| Free Cash Flow Yield | -488.5% |